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Little is known about the metabolome fingerprint of pulse consumption. The 21 
study of robust and accurate biomarkers for pulse dietary assessment has great 22 
value for nutritional epidemiology regarding health benefits and their 23 
mechanisms. To characterize the fingerprinting of dietary pulses (chickpeas, 24 
lentils and beans), spot urine samples from a subcohort from the PREDIMED 25 
study were stratified, using a validated food frequency questionnaire. Non-pulse 26 
consumers (≤ 4 g/day of pulse intake) and habitual pulse consumers (≥ 25 27 
g/day of pulse intake) were analysed using a 1H-NMR metabolomics approach 28 
combined with multi- and univariate data analysis. Pulse consumption showed 29 
differences through 16 metabolites coming from (i) choline metabolism, (ii) 30 
protein-related compounds, and (iii) energy metabolism (including lower urinary 31 
glucose). Stepwise logistic regression analysis was applied to design a 32 
combined model of pulse exposure, which resulted in glutamine, dimethylamine 33 
and 3-methylhistidine. This model was evaluated by receiver operating 34 
characteristic curve (AUC > 90% in both training and validation sets). The 35 
application of NMR-based metabolomics to pulse exposure highlighted new 36 
candidates for biomarkers of pulse consumption, the role of choline metabolism 37 
and the impact on energy metabolism, generating new hypotheses on energy 38 
modulation. Further intervention studies will confirm these findings. 39 
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1. Introduction 44 
The Mediterranean diet (MD) is a dietary pattern characterized by a high intake 45 
of vegetables, cereals, pulses, nuts, fish and olive oil, low intake of red meat 46 
and processed meat products, and low to moderate consumption of poultry, 47 
wine and dairy products.1 Moreover, the MD has been demonstrated to be 48 
useful in the prevention of type 2 diabetes, obesity, inflammatory diseases, 49 
cardiovascular diseases (CVD) and even cancer.2–5  50 
One of the components of the MD is pulses, which constitute an excellent food, 51 
providing protein, dietary fibre, many vitamins and minerals, as well as a great 52 
variety of phytochemicals.6–8 Thus, they could contribute to the beneficial effects 53 
reported for this dietary pattern.9 In addition, pulses are increasingly being 54 
recognized for their role in promoting good health.6,10–12 Indeed, habitual pulse 55 
consumption is included in the main dietary guidelines worldwide, including the 56 
MD,13 the Dietary Guidelines for Americans14,15 and the Nordic Diet,16 among 57 
others, and they are also advocated in view of their low environmental impact 58 
compared with other protein sources.17 59 
Metabolomics is a powerful tool for identifying food exposure biomarkers in 60 
humans18 and provides new information on dietary components and dietary 61 
patterns.19 In this regard, the evaluation of dietary exposure through a 62 
combination of biomarkers enables a better understanding of compliance to a 63 
dietary exposure.20 Moreover, little is known about the metabolome fingerprint 64 
from legume consumption either individually or as a complex food group, with 65 
only a few tentative biomarkers being described.21,22 66 
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Determining the changes in the urinary metabolome, new biomarkers of intake 67 
and/or their effect may reveal potential modifications in diet-related physiology 68 
both in healthy and diseased individuals.23 Furthermore, metabolomic 69 
approaches have been proposed for evaluating the relationship between 70 
nutrition and health status.24 In light of this connection, recent scientific 71 
publications have pointed out the potential health benefits of legumes in chronic 72 
diet-related diseases, such as CVD and type 2 diabetes mellitus.6,8,25,26 Thus 73 
the application of nutrimetabolomics to a high-cardiovascular-risk population 74 
could provide new insights into this potential relationship.  75 
In the present work, we compared the metabolome profiles of reported pulse 76 
consumption in a free-living population to find putative biomarkers reflecting 77 
intake and/or effect of intake. Analysis of individuals under free-living conditions 78 
enables more representative data to be obtained on the metabolome 79 
fingerprints of pulse consumers. In light of this, a better understanding of the 80 
specific role of pulse consumption in terms of health benefits, beyond their 81 
excellent nutritional profile, is expected. Therefore, the aim of the present study 82 
was to investigate dietary pulse fingerprinting in spot urine using an untargeted 83 
1H-NMR metabolomic approach on a free-living subcohort from the PREDIMED 84 
study. For this purpose, we mainly focused on urinary biomarkers of a complex 85 
pulse exposure comprising chickpeas, lentils and beans in a combined urinary 86 
biomarker model. 87 
 88 
2. Material and methods 89 
2.1. PREDIMED subcohort study  90 
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For the present study, a subsample of 50 participants from the PREDIMED 91 
study (ISRCTN 35739639; http://www.predimed.org) was taken. The 92 
PREDIMED study is a large, parallel-group, multicentre, randomized and 93 
controlled clinical trial assessing the effects of an MD on the primary prevention 94 
of CVD. The trial protocol was conducted according to the Declaration of 95 
Helsinki and was approved by the Institutional Review Boards of all the centres 96 
involved. Briefly, free-living participants (55–80 years old) without CVD that 97 
fulfilled at least one of the two following criteria – type 2 diabetes mellitus or 98 
three or more major cardiovascular risk factors – were included for an MD 99 
supplemented either with extra virgin olive oil or mixed nuts.27 The exclusion 100 
criteria were CVD, any severe chronic illness, drug or alcohol addiction, a 101 
history of allergy, or intolerance to olive oil or nuts. The subcohort consisted of a 102 
random sample of participants at high cardiovascular risk, recruited from the 103 
Barcelona and Valencia PREDIMED centres. The PREDIMED study design and 104 
137-item validated food frequency questionnaires (FFQs) used have been 105 
reported elsewhere.28,29 Data reported from the FFQs included information on 106 
total legume consumption, and disaggregated type of legume consumed. 107 
 108 
2.2. Stratification of the study population 109 
2.2.1. Defining potential consumers 110 
Both the use of FFQs and the population stratification of a cohort of individuals 111 
by consumption have demonstrated an effective approach for the study of 112 
biomarkers of food consumption.30–32 Participants were classified into two levels 113 
(consumers and non-consumers) of habitual intake of dietary pulse foods 114 
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(chickpeas, lentils or beans) based on the analysis of the validated FFQs 115 
(Supporting Information, Table S1). Intake of pulses was calculated as the sum 116 
of consumed chickpeas, lentils and beans. Non-pulse (NP) consumers were 117 
defined as subjects with sporadic or non-consumption (≤ 4.00 g/day) of pulses. 118 
Habitual pulse (HP) consumers were set at a consumption of ≥ 25.71 g/day, 119 
regularly. In order to explore global pulse consumption, individuals that did not 120 
consume the three kinds of pulses simultaneously were also excluded. 121 
Additionally, the condition of sporadic or non-intake of peas (≤ 4 g/day) was 122 
taken into consideration, since the features of this type of legume are not similar 123 
to the others.33 No other legume types were considered.  124 
 125 
2.2.2. Selecting individuals by consumption 126 
Spot urine samples were matched to corresponding individual FFQ data. From 127 
a cohort of 828 individuals, 25 subjects were deﬁned as NP consumers and 37 128 
as HP consumers (none of the other participants from both pulse consumer 129 
groups fulfilled any criteria). In order to reduce the potential sources of 130 
variability not related to pulse exposure, the number of HP consumers was 131 
balanced against NP consumers (HP = 25, NP = 25). Finally, dietary data, 132 
anthropometry, biochemical parameters, health status and medication were 133 
explored with a view to discarding any variability unrelated to pulse 134 
consumption. 135 
 136 
2.3. Metabolomics analysis 137 
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2.3.1. Urine sample analysis and data processing  138 
Morning fasting spot urine samples were collected, aliquoted, encoded and 139 
frozen at -80 ºC until were use. Sample preparation was based on the 140 
methodology previously published.19 The 1H-NMR urinary spectra were 141 
acquired using a Varian-Inova-500 MHz NMR spectrometer with presaturation 142 
of the water resonance using a NOESYPRESAT pulse sequence. During the 143 
acquisition, the internal temperature was kept constant at 298 K. An exponential 144 
window function was applied to the free induction decay (FID) with a line-145 
broadening factor of 0.3 Hz prior to Fourier transformation. For each sample, a 146 
total of 128 scans were collected into 32 K data points with a spectral width of 147 
14 ppm at 300 K, an acquisition time of 3.2 s and a relaxation delay of 3 s.  148 
1H-NMR spectra were phased, baseline-corrected and calibrated (TSP, 0.0 149 
ppm) using TopSpin software (version 3.0, Bruker, BioSpin, Germany). After 150 
baseline correction, original spectral data were bucketed in intelligent bucketing 151 
domains of 0.005 ppm with ACD/NMR Processor 12.0 software (Advanced 152 
Chemistry Development, Toronto, Canada). The water signal and noise regions 153 
above 9.5 ppm and below 0.5 ppm were excluded from the analysis. 154 
Data were submitted to MetaboAnalyst 3.0 for interquartile range filtering and 155 
normalization by the sum of the intensities of the spectra.34 156 
 157 
2.3.2. Statistical analysis 158 
The NMR data set was log-transformed, Pareto-scaled and posteriorly analysed 159 
in a multivariate approach using SIMCA-P+13.0 software (Umetrics, Umeå, 160 
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Sweden). Interindividual variation may confuse the effects of intervention, 161 
particularly in multivariate data of high dimensionality. Therefore, partial least 162 
squares discriminant analysis with orthogonal signal correction (OSC-PLS-DA) 163 
was used to explore the differences in metabolomes among the pulse 164 
consumption.35 OSC filtration was used to reduce the variability not associated 165 
with dietary classification, as has been done in other published 166 
nutrimetabolomic studies.19,31,36 The quality of the models was evaluated by the 167 
proportion of the variance of the response variable that is explained by the 168 
model (R2Y) and the predictive ability (Q2) parameters.35 Validation of the 169 
models and the evaluation of the degree of overfitting were carried out using a 170 
permutation test (n = 200), and the correlation coefficient between the original Y 171 
and the permuted Y plotted against the cumulative R2 and Q2 was calculated. 172 
Those NMR signals with variable importance for projection (VIP) values ≥1 in 173 
the component of the OSC-PLS-DA model were selected as being relevant for 174 
explaining the differences in metabolic profiles. These variables were further 175 
studied through the univariate Student’s t-test among HP and NP consumers to 176 
assess the statistical significances. Multiple tests were controlled by the false 177 
discovery rate (FDR). Statistical significance was considered at an FDR-178 
adjusted p-value <0.05. Then, Cliff's delta was chosen for estimation of the 179 
effect size37 and calculated for each feature. 180 
 181 
2.3.3. Metabolite identification 182 
Metabolite identification was performed using the Chenomx NMR Suite 183 
Professional Software package (version 8.1; Chenomx Inc., Edmonton, 184 
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Canada) and by comparing NMR spectral data to those available in databases 185 
such as the Human Metabolome Database (http://www.hmdb.ca), the Biological 186 
Magnetic Resonance Data Bank (http://www.bmrb.wisc.edu) and the Madison 187 
Metabolomics Consortium Database (www.mmcd.nmrfam.wisc.edu), along with 188 
the existing NMR-based metabolomics literature. Further, a Pearson’s 189 
correlation test and clustering analysis with Pearson distance and Ward’s 190 
minimum variance using PermutMatrix 1.9.3.0 software38 were applied in order 191 
to identify the signals corresponding to the same metabolite. 192 
 193 
2.4. Study of combined urinary biomarker model 194 
The interaction between gender and the resulting metabolites was evaluated by 195 
a logistic regression for discarding any effect on the biomarkers. Then, these 196 
metabolites were submitted to a stepwise logistic regression analysis (IBM 197 
SPSS Statistics 20 software, SPSS, Inc., Chicago, IL, USA) to evaluate whether 198 
the combination of more than one biomarker improves the discrimination20 of 199 
pulse consumption. The models were constructed through a dichotomous 200 
variable of pulse consumption as dependent variable and identified metabolites 201 
as independent variables, with a p-value of <0.05 as a condition required for 202 
entering and remaining in the model. For validation of models, the analysis with 203 
a training set of 2/3 of the samples (removing 1/3 of the individuals as the 204 
validation set) was permuted 20 times. Spearman’s rank correlation coefficient 205 




The global performance of the models was evaluated by receiver operating 208 
characteristic (ROC) curve and estimation of the area under the curve (AUC) 209 
values. The optimum cut-off for sensitivity and specificity of the biomarkers was 210 
determined as the minimum distance to the top-left corner.39  211 
 212 
3. Results 213 
A flow chart of the participants allocated in the present study is presented in the 214 
Supplementary Information (Figure S1). Anthropometric measurements and 215 
biochemical analyses were performed using standardized methods.28 HP 216 
consumers showed a pulse consumption of 38.45 ± 14.68 g/day, while NP 217 
consumers reported a consumption of 3.75 ± 3.95 g/day (mean ± SD). The 218 
characteristics of participants classified by pulse consumption (Table S2) are 219 
presented in the Supplementary Information. The stratified populations were not 220 
different in terms of disease (type 2 diabetes mellitus or cardiovascular risk 221 
factors), medications or biochemical parameters, among other data. Subjects 222 
who were HP consumers showed higher amounts of both dietary fibre (p < 223 
0.01) and polyunsaturated fatty acid (p < 0.05) intakes as a consequence of 224 
legume macronutrient composition.6,40 No significances other than pulses were 225 
found with regard to food intake. 226 
 227 
3.1. Selection of significant biomarkers related to pulse consumption 228 
For the analysis of the features belonging to pulse consumption in the urinary 229 
metabolome of the HP and NP consumers, an orthogonal signal correction was 230 
applied before PLS-DA analysis. The OSC-PLS-DA analysis of the two groups 231 
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resulted in a latent variable model with R2Y and Q2 values of 0.954 and 0.809, 232 
respectively, indicating that the model was able to classify each subject in the 233 
correct consumption group. The corresponding permutation tests showed 234 
negative Q2 intercepts with a value of -0.164, implicating validation of the 235 
model.35 With the purpose of selecting the most discriminative urinary markers 236 
of consumption, only the statistically significant variables coming from both 237 
multi- and univariate analyses simultaneously were considered. 238 
 239 
3.2. Identified biomarkers of habitual pulse consumption 240 
A total of 16 compounds were identified as discriminant metabolites of pulse 241 
consumption. Metabolites and chemical shifts identified corresponding to 242 
statistical analyses are presented in Table 1. The total number of metabolites 243 
related to pulse consumption was divided into categories as follows: (i) choline 244 
metabolism: choline, dimethylglycine, trimethylamine-N-oxide (TMAO) and 245 
dimethylamine; (ii) protein-related compounds: 3-methylhistidine, 246 
methylguanidine, phenylalanine, glutamine and n-acetylglutamine; and (iii) 247 
energy metabolism: glucose, leucine, isovalerylglycine, and isobutyric, 248 
acetoacetic, citric and cis-aconitic acids. 249 
 250 
3.3. Combined urinary biomarker approach 251 
Logistic regression analysis revealed that there was no significant interaction 252 
between gender and the metabolites (p>0.05; all) shown in Table S3 253 
(Supplementary Information). To study the improvement of the discrimination 254 
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between groups (HP and NP consumers), a conditional stepwise variable 255 
selection method, through a binary logistic regression analysis, was used on a 256 
combination of more than one discriminant metabolite. Table S4 257 
(Supplementary Information) shows the resulting metabolites included in all 20 258 
permuted models and the contribution to the model. Three metabolites were 259 
included in the fitted model according to the maximum AUC, which contained 260 
two protein-related metabolites (glutamine and 3-methylhistidine) and one 261 
choline-related metabolite (dimethylamine). These three metabolites correlated 262 
individually with the pulse consumption. However, the combined model 263 
exhibited the strongest correlation (r=0.73, p<0.01) with the pulse exposure, as 264 
shown in Table S5 (Supplementary Information). 265 
The ROC curve analysis was used to evaluate the combined metabolite model 266 
and their metabolites using both training and validation sets separately. The 267 
highest AUC was for the combined metabolite model for both training (AUC = 268 
95.6%) and validation (AUC = 94.4%) sets, including glutamine, 3-269 
methylhistidine and dimethylamine followed by the individual metabolites 3-270 
methylhistidine (AUC = 82.4%), glutamine (AUC = 81.6%) and dimethylamine 271 
(AUC = 75.0%), as shown in Figure 1. The equations generated from the 272 
logistic regression and the AUCs from the models with their sensitivity and 273 




Figure 1. Receiver operating characteristic (ROC) curves of combined model 276 
(continuous line) with the area under the ROC curve and of included individual 277 
metabolites (discontinuous lines) in the training (A) and validation (B) sets. 278 
 279 
4. Discussion 280 
In this study, we present a panel of different urinary metabolites related to 281 
habitual pulse exposure using a 1H-NMR-based untargeted nutrimetabolomic 282 
approach in a free-living population. In addition, high correlations were found 283 
when the exposure was assessed as a continuous variable (defined by the 284 
combined biomarker panel).  285 
 286 
4.1. Characterization of pulse fingerprinting in urine 287 
4.1.1. Pulse metabolomic fingerprinting and choline metabolism  288 
Several compounds found in the spot urine of pulse consumers are related to 289 
choline. Thus pulses, as a rich source of choline,41 may be the precursor of 290 
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additional metabolites that are susceptible to microbial degradation generating 291 
new compounds.42 Therefore, the increase of several intermediates of choline 292 
metabolism, such as choline itself, TMAO and dimethylamine, appears to be a 293 
consequence of the microbial activity in HP consumers. In relation to this, De 294 
Filippis and co-workers found an inverse correlation between urinary TMAO and 295 
vegetarian diets compared with omnivore ones. However, they suggest different 296 
food sources of carnitine and choline such as eggs, beef, pork and fish.43 297 
Hence, legumes from vegetarian diets should be proposed as a food choline 298 
source. The increase of dimethylamine, which is also a downstream product of 299 
choline, supports the microbial degradation of TMAO from choline. Furthermore, 300 
TMAO was identified as a major source of urinary dimethylamine in humans,44 301 
directly related to gut microbiota metabolism.45 On the other hand, the increase 302 
of urinary dimethylglycine may also come from the choline contained in pulses. 303 
The enzymes choline dehydrogenase, betaine aldehyde dehydrogenase and 304 
betaine homocysteine methyltransferase lead to dimethylglycine from choline.46 305 
Therefore, the results of the present study suggest a possible impact on urinary 306 
metabolome by choline from pulses that is degraded via both (i) mammalian 307 
pathways in which choline is converted to dimethylglycine through betaine, and 308 
(ii) microbial metabolism in which choline is degraded to trimethylamine, TMAO 309 
and dimethylamine. For this reason, we propose dimethylamine and 310 
dimethylglycine in spot urine as potential candidates for biomarkers of pulse 311 
consumption. Nevertheless, these choline-related metabolites need to be 312 
further explored in controlled studies confirming that they are food intake 313 
biomarkers instead of reflecting metabolic differences due to the pulse 314 
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consumption. Figure 2 shows both proposed pathways for downstream 315 
products of choline.  316 
 317 
 318 
Figure 2. Proposed pathways for choline degradation from pulses including 319 
significant metabolites in HP consumers in the present study. Image courtesy of 320 
Francisco Madrid-Gambin. Copyright 2016.  321 
 322 
4.1.2. Pulse metabolomic fingerprinting and protein-related compounds 323 
With regard to the increases in glutamine and the acetylated form n-324 
acetylglutamine, several explanations may be proposed. Glutamine and n-325 
acetylglutamine could come from dietary sources since glutamine is found in 326 
high-protein foods, such as pulses.47 Another explanation could be the 327 
alteration of urinary levels previously shown in this type of population,48 affected 328 
by pulse consumption. There was a higher excretion of 3-methylhistidine in HP 329 
consumers. This metabolite is a biomarker of meat and fish consumption,49 330 
denoting a potential role as a biomarker of consumption. Interestingly, all food 331 
sources of this metabolite are also protein sources, including pulses as a 332 
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vegetable source, as highlighted in the present study. However, 3-333 
methylhistidine is also a muscle protein breakdown that is sensitive to gender 334 
and age.50 Methylguanidine is derived from protein catabolism and from the 335 
breakdown of creatinine,51,52 therefore it may be related to protein from pulses. 336 
 337 
4.1.3. Pulse metabolomic fingerprinting and energy metabolism  338 
The signals of several usual metabolites were altered between the two groups. 339 
However, the definition as food intake biomarkers is controversial. Instead, they 340 
probably reflect metabolic differences associated with being a low and high 341 
consumer, based on the study design. Most of the biomarkers found in the 342 
present study are metabolites related to energy metabolism. The lower 343 
excretion of acetoacetic acid, glucose and tricarboxylic acid (TCA) cycle 344 
intermediates (citric and cis-aconitic acids) appears to involve a different energy 345 
modulation according to the pulse consumption. This fact is in part reinforced by 346 
changes in BCAAs and subproducts, which are involved in energy metabolism. 347 
For example, isobutyric acid is a short-chain fatty acid that is a product of BCAA 348 
catabolism of valine, which is a glucogenic BCAA metabolized via the 349 
methylmalonyl-CoA in the TCA cycle.53 On the other hand, acetoacetic acid is a 350 
ketone body produced in the human liver for fatty acid breakdown,54 which 351 
serves as a source of energy when normal glycolysis is altered. Interestingly, 352 
acetoacetic acid was shown to be increased in diabetes mellitus.55 Hence, we 353 
hypothesize that gluconeogenesis may be diminished in pulse consumers, 354 
supported by the urinary reduction of acetoacetic and isobutyric acids (lower 355 
fatty acid catabolism), and the reduction of TCA cycle intermediates and urinary 356 
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glucose (better use of glucose). Furthermore, it was observed that pulse 357 
consumption has a glucose-lowering role in diabetes mellitus,56,57 thereby 358 
explaining the lower plasma glucose concentration and lower urinary excretion. 359 
Figure 3 shows the resulting endogenous metabolites connected to the TCA 360 
cycle. Nevertheless, the small sample size that resulted after the stratification of 361 
the population leads to only exploratory results that should be confirmed. 362 
The role of other findings such as increases of leucine and phenylalanine in 363 
pulse consumers is unclear. On the one hand, these habitual urinary 364 
compounds could be increased as a consequence of pulses being the source. 365 
However, another explanation of these findings could support the hypothesis 366 
above. Leucine, which is an acetoacetic acid precursor, may modulate glucose 367 
metabolism through oxidation, as well as insulin signalling and release. In 368 
addition, stimulation of glucose recycling via the glucose-alanine cycle by 369 
leucine may inhibit protein breakdown.58,59 However, alterations in urinary 370 
leucine have also been proposed for the prediction of diabetes mellitus, 371 
probably related to the perturbed energy metabolism.55 The origin of increased 372 
phenylalanine is also uncertain. This ketogenic amino acid can stimulate insulin 373 
and glucagon concentration, enhancing glucose homeostasis,60 and is also 374 
altered in an insulin-resistant state and obesity.61 Overall, the consumption of 375 





Figure 3. Modified metabolites found in HP consumers connected to energy 379 
metabolism. 380 
 381 
4.2. New biomarker panel to characterize habitual pulse consumption 382 
To delimit the prediction of habitual pulse intake, comprising lentils, chickpeas 383 
and beans, a combination of more than one discriminatory metabolite had to be 384 
studied. The combination of three metabolites enhanced considerably the AUC 385 
and the confidence interval of the model in comparison with individual 386 
metabolites, as shown in Table 2. The developed model indicated that 387 
glutamine, 3-methylhistidine and dimethylamine were the strongest candidates 388 
for exposure biomarkers. It is important to note that the role of the component 389 
coming from choline metabolism suggests the importance of this metabolite as 390 
a biomarker of intake. Interestingly, metabolites displaying changes in energy 391 
metabolism were scarcely considered by the stepwise logistic regression. None 392 
of the other metabolites entered the model, probably as a result of collinearity in 393 
the evidence provided by these compounds, which may originate from the same 394 
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metabolic pathways, giving similar biological or dietary information.36 Instead, 395 
two metabolites related to protein coming from pulses and one connected to 396 
microbiota choline degradation were established in the combined metabolite 397 
model, giving complementary information, showing a better discrimination (AUC 398 
> 90% in both training and validation sets) than each metabolite individually 399 
(AUC < 90% in all cases), and reinforcing the improved capacity of biomarker 400 
patterns to distinguish between different dietary exposures.  401 
 402 
5. Conclusions 403 
We applied an untargeted 1H-NMR-based metabolomic strategy to distinguish 404 
the urinary metabolome of habitual pulse consumption in a free-living 405 
population. Stepwise logistic regression analysis exhibited a useful approach to 406 
designing a combined urinary biomarker model taking into consideration the 407 
different characteristics of pulses. With regard to food metabolome, this study 408 
points to a central role of choline contained in pulses and breakdown products 409 
such as dimethylglycine, TMAO and dimethylamine. Protein-related compounds 410 
such as glutamine, 3-methylhistidine and methylguanidine were also increased 411 
in the urine of HP consumers. The combined metabolite model indicated that 412 
dimethylamine, 3-methylhistidine and glutamine were the strongest candidates 413 
for exposure prediction. In relation to energy metabolism, numerous compounds 414 
connected to the TCA cycle, including BCAAs and acetoacetic acid, were 415 
modified, denoting a substantial impact on energy metabolism modulation and 416 
on urinary glucose in this population. However, since the status of type 2 417 
diabetes mellitus or three or more major cardiovascular risk factors in the 418 
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studied population could have a distinctive energy modulation, properly 419 
controlled interventions could confirm the findings observed in this cross-420 
sectional study.  421 
 422 
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Table 1. Tentative discriminant metabolites derived from the multi- and 679 















Choline ↑ 3.19 (s) 3.27 x 10
-2
 0.475 
Dimethylglycine ↑ 2.93 (s) 3.81 x 10
-2
 0.386 
TMAO ↑ 3.27 (s) 7.29 x 10
-3
 0.485 


























Methylguanidine ↑ 2.83 (s) 3.72 x 10
-4
 0.635 























Acetoacetic acid ↓ 2.27 (s) 1.95 x 10
-2
 -0.408 












Isobutyric acid ↓ 1.06 (d) 1.29 x 10
-2
 -0.446 
aAll features have VIP values ≥1.0 in the corresponding OSC-PLS-DA model.
 †P-value 681 
of Student’s t-test with False Discovery Rate correction. §Estimation of the effect size 682 
by Cliff’s delta with thresholds: |n|<0.330 "small", 0.330>|n|<0.474 "medium" and 683 
|n|>0.474 "large". TMAO, trimethylamine-N-oxide. s: singlet, d: doublet, t: triplet, dd: 684 
double doublet, m: multiplet. 685 
  686 
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Table 2. Receiver operating characteristic (ROC) curve parameters of 687 




 Sensitivity (%) Specificity (%) AUC (95% CI) 
Combined model Training 88.2 93.7 95.6 (89.4–100.0) 
 Validation 87.5 88.9 94.4 (84.1–100.0) 
3-Methylhistidine Training 76.5 87.5 82.4 (67.7–97.0) 
 Validation 87.5 77.8 80.6 (56.2–100.0) 
Glutamine Training 76.5 81.2 81.6 (67.0–96.3) 
 Validation 87.5 77.8 84.7 (65.3–100.0) 
Dimethylamine Training 82.4 62.5 75.0 (57.8–92.2) 
 Validation 50.0 66.7 68.1 (40.4–100.0) 
AUC: area under the ROC curve. CI: confidence interval. †Corresponding to 2/3 of the 690 
population for the training and 1/3 for the validation set. 691 
  692 
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Figure 1. Receiver operating characteristic (ROC) curves of combined model 693 
(continuous line) with the area under the ROC curve and of included individual 694 
metabolites (discontinuous lines) in the training (A) and validation (B) sets. 695 
 696 
Figure 2. Proposed pathways for choline degradation from pulses including 697 
significant metabolites in HP consumers in the present study. 698 
 699 
Figure 3. Modified metabolites found in HP consumers connected to energy 700 
metabolism. 701 
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